Publications by authors named "D Inotai"

Claim this Profile
D
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Attila Tordai, Andras Bors, Katalin Piroska Kiss, Katalin Balassa, Hajnalka Andrikovics, Dora Inotai

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Komorbidität von lokalisierter Sklerodermie und primär biliärer Cholangitis.
Gábor Bali, Anikó Szilvási, Dóra Inotai, Ágnes Varga, Miklós Sárdy

J Dtsch Dermatol Ges· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity of localized scleroderma and primary biliary cholangitis.
Gábor Bali, Anikó Szilvási, Dóra Inotai, Ágnes Varga, Miklós Sárdy

J Dtsch Dermatol Ges· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura.
György Sinkovits, Ágnes Szilágyi, Péter Farkas, Dóra Inotai, Anikó Szilvási

Front Immunol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.
Katalin Balassa, Hajnalka Andrikovics, Peter Remenyi, Arpad Batai, Aniko Szilvasi, Dora Inotai

Hum Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis